Non Anticoagulant Effects of Heparin: Implications for Animal Models of Peritoneal Dialysis

An S. De Vriese,Siska Mortier,Norbert H. Lameire
DOI: https://doi.org/10.1177/089686080102103s65
2001-12-01
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Abstract:Heparin is a glycosaminoglycan with well-known anticoagulant activity. That property is used in animal models of peritoneal dialysis to maintain catheter patency and to prevent the development of peritoneal adhesions. However, heparin has a host of biologic actions beyond its role as an anticoagulant. Heparin modulates the activity of various inflammatory cells, affects the synthesis of extracellular matrix, has antiproliferative effects on several cell types, and influences neoangiogenesis. By virtue of those actions, intraperitoneally administered heparin may interfere with peritoneal membrane homeostasis. The potential side effects of heparin use in animal models of peritoneal dialysis should be recognized to permit correct interpretation of experimental studies conducted in those models.
What problem does this paper attempt to address?